Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Gains License to DNAPrint s SNPs

NEW YORK, Oct 24 – Orchid BioSciences has purchased an option to co-develop and co-commercialize DNAPrint genomics’ SNP-disease associations and other intellectual properties, the companies said Tuesday.

The option provides Orchid exclusive rights to negotiate partnership terms with DNAPrint for existing and future products and properties, including genetic algorithms, software, and information resources such as SNP and haplotype associations with complex human traits and diseases.

Other terms of the agreement were not disclosed.

DNAPrint is developing genetic analytics and information resources for personalized medicine. The company aims to provide practitioners of genomic research and personalized medicine with a comprehensive system for complex trait dissection and patient classification.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.